Marketing Masterclass: Salesforce Effectiveness: Is the Pharmaceutical Industry going in the Right Direction?

Abstract

As the healthcare environment for the pharmaceutical industry is undergoing major changes, salesforce effectiveness replaces the traditional ‘size sells paradigm’. Consequently, pharmaceutical companies are being forced to optimise both their bottom and top line. This paper applied a quantitative approach based on an interactive survey to analyse these developments. The survey results confirmed major trends, including the growing importance of payors, and showed that the development of salesforce size and structure will soon head in a different direction as sales representative numbers stop growing. Clearly, there is no silver bullet with which pharmaceutical companies can increase salesforce effectiveness. The industry is, therefore, preparing for the future by exploring and piloting innovative sales and marketing models. Once they have identified a suitable approach to salesforce effectiveness and implemented it in the best possible way, companies can create competitive advantages.

Keywords

European pharmaceuticals salesforce effectiveness Rx suppliers interactive survey

Get full access to this article

View all access options for this article.

References

Wadman

Hütt

(2004). The need for a new go-to-market strategy in Europe: How to survive and thrive in the new more complex healthcare marketplace. Int. J. Med. Market. 4, 154–162.

Bhalla

Evgeniou

Lerer

(2004). Customer relationship management and networked healthcare in the pharmaceutical industry. Int. J. Med. Market. 4, 370–379.

Pesse

Erat

(2006). The network is the customer: Setting the stage for fundamental change in pharmaceutical sales and marketing. J. Med. Market. 6, 165–171.

Forsyth

(2004). Digital marketing — content management: A prerequisite to marketing and sales effectiveness. Int. J. Med. Market. 4, 228–234.

Donaldson

Wright

(2004). Salesforce automation in the UK pharmaceutical industry: Why is the strategic potential of these systems not being realized in practice?. Int. J. Med. Market. 4, 251–263.